This protocol describes the isolation, enrichment, and maintenance of medulloblastoma tumor stem cells derived from mutant mice with ectopic Sonic hedgehog pathway activity.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
This protocol describes the isolation, enrichment, and maintenance of medulloblastoma tumor stem cells derived from mutant mice with ectopic Sonic hedgehog pathway activity.
Brain tumors have been suggested to possess a small population of stem cells that are the root cause of tumorigenesis. Neurosphere assays have been generally adopted to study the nature of neural stem cells, including those derived from normal and tumorous tissues. However, appreciable amounts of differentiation and cell death are common in cultured neurospheres likely due to sub-optimal condition such as accessibility of all cells within sphere aggregates to culture medium.
Medulloblastoma, the most common pediatric CNS tumor, is characterized by its rapid progression and tendency to spread along the entire brain-spinal axis with dismal clinical outcome. Medulloblastoma is a neuroepithelial tumor of the cerebellum, accounting for 20% and 40% of intracranial and posterior fossa tumor in childhood, respectively1. It is now well established that Shh signaling stimulates proliferation of cerebellar granule neuron precursors (CGNPs) during cerebellar development 2-4. Numerous studies using mouse models, in which the Shh pathway is constitutively activated, have linked Shh signaling with medulloblastoma 5-9.
A recent report has shown that a subset of medulloblastoma cells derived from Patched1LacZ/+ mice are cancer stem cells, which are capable of initiating and propogating tumors 10. Here we describe an efficient method to isolate, enrich and maintain tumor stem cells derived from several mouse models of medulloblastoma, with constitutively activated Shh pathway due to a mutation in Smoothened (11, hereon referred as SmoM2), a GPCR that is critical for Shh pathway activation. In every isolated medulloblastoma tissue, we were able to establish numerous highly proliferative colonies. These cells robustly expressed several neural stem cell markers such as Nestin and Sox2, can undergo serial passages (greater than 20) and were clonogenic. While these cultured tumor stem cells were relatively small, often bipoar with high nuclear to cytoplasmic ratio when cultured under conditions favoring stem cell growth, they dramatically altered their morphology, extended multiple cellular processes, flattened and withdrew from the cell cycle upon switching to a cell culture medium supplemented with 10% fetal bovine serum. More importantly, these tumor stem cells differentiated into Tuj1+ or NeuN+ neurons, GFAP+ astrocytes and CNPase+ oligodendrocytes, thus highlighting their multi-potency. Furthermore, these cells were capable of propagating secondary medulloblastomas when orthotopically transplanted into host mice.
1. Micro-dissection of Tumor-bearing Cerebellum, Dissociation of Tumor Tissue and Plating
Access restricted. Please log in or start a trial to view this content.
We describe an efficient way to isolate, enrich and maintain medulloblastoma stem cells from primary tumor tissue retrieved from mutant mice with constitutively active Hedgehog signaling. We found that one critical step in successfully establishing a healthy tumor stem cell line is the Accutase treatment used during dissociation of the primary tumor tissue. In our experience, when first dissociating tumor tissue from the cerebellum, 4 minutes of 50% Accutase treatment at 37°C, followed by 3 minutes of repetitive pipe.......
Access restricted. Please log in or start a trial to view this content.
No conflicts of interest declared.
This study was supported by grants from the Vanderbilt-Ingram Cancer Center Support Grant (P30 CA068485), the Childhood Brain Tumor Foundation and the National Institutes of Health (NS042205).
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| Neurobasal medium | Invitrogen | 21103049 | |
| hEGF | Invitrogen | PHG0311 | 25ng/ml |
| bFGF | Invitrogen | PHG0023 | 25ng/ml |
| N2 | Invitrogen | 17502048 | 1X |
| B27(-RA) | Invitrogen | 12587010 | 1X |
| Accutase | Invitrogen | A1110501 | 50% |
| Gelatin | Sigma-Aldrich | G1393 | 0.1% |
| Glutamine | Invitrogen | 25030081 | 2mM |
| Primaria dishes | Fisher Scientific | 087724C | |
| Sox2 antibody | EMD Millipore | MAB4343 | Mouse, 1:1000 |
| Nestin antibody | DSHB | rat401 | Mouse, 1:200 |
| YFP antibody | Molecular Probes, Life Technologies | A11122 | Rabbit, 1:2000 |
| GFAP antibody | Neuromics | CH22102 | Chicken, 1:1000 |
| Tuj1 antibody | Sigma-Aldrich | T5076 | Mouse, 1:2000 |
| NeuN antibody | EMD Millipore | MAB377 | Mouse, 1:2000 |
| CNPase antibody | EMD Millipore | MAB326 | Mouse, 1:1000 |
Access restricted. Please log in or start a trial to view this content.